Sera Prognostics Inc (SERA)
9.51
-0.41
(-4.13%)
USD |
NASDAQ |
May 07, 16:00
9.51
0.00 (0.00%)
After-Hours: 16:00
Sera Prognostics Enterprise Value: 272.58M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | 272.58M |
May 03, 2024 | 302.74M |
May 02, 2024 | 295.61M |
May 01, 2024 | 289.12M |
April 30, 2024 | 329.98M |
April 29, 2024 | 312.47M |
April 26, 2024 | 299.50M |
April 25, 2024 | 286.20M |
April 24, 2024 | 276.48M |
April 23, 2024 | 273.88M |
April 22, 2024 | 267.72M |
April 19, 2024 | 267.07M |
April 18, 2024 | 268.37M |
April 17, 2024 | 264.80M |
April 16, 2024 | 268.69M |
April 15, 2024 | 276.48M |
April 12, 2024 | 264.15M |
April 11, 2024 | 315.71M |
April 10, 2024 | 268.04M |
April 09, 2024 | 273.23M |
April 08, 2024 | 265.45M |
April 05, 2024 | 257.67M |
April 04, 2024 | 255.07M |
April 03, 2024 | 257.34M |
April 02, 2024 | 249.56M |
Date | Value |
---|---|
April 01, 2024 | 254.75M |
March 28, 2024 | 245.99M |
March 27, 2024 | 257.67M |
March 26, 2024 | 258.97M |
March 25, 2024 | 247.62M |
March 22, 2024 | 275.18M |
March 21, 2024 | 254.43M |
March 20, 2024 | 243.40M |
March 19, 2024 | 244.37M |
March 18, 2024 | 241.46M |
March 15, 2024 | 251.18M |
March 14, 2024 | 234.36M |
March 13, 2024 | 241.02M |
March 12, 2024 | 241.02M |
March 11, 2024 | 243.55M |
March 08, 2024 | 253.06M |
March 07, 2024 | 237.21M |
March 06, 2024 | 238.16M |
March 05, 2024 | 251.16M |
March 04, 2024 | 241.65M |
March 01, 2024 | 247.04M |
February 29, 2024 | 233.72M |
February 28, 2024 | 226.75M |
February 27, 2024 | 233.09M |
February 26, 2024 | 224.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-70.43M
Minimum
Jun 13 2022
329.98M
Maximum
Apr 30 2024
64.07M
Average
30.74M
Median
Apr 18 2023
Enterprise Value Benchmarks
RadNet Inc | 4.501B |
DermTech Inc | -33.93M |
iSpecimen Inc | -2.496M |
23andMe Holding Co | -7.431M |
Progyny Inc | 2.755B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.925M |
Revenue (Quarterly) | 0.041M |
Total Expenses (Quarterly) | 8.889M |
EPS Diluted (Quarterly) | -0.25 |
Gross Profit Margin (Quarterly) | 41.46% |
Profit Margin (Quarterly) | -19.33K% |
Earnings Yield | -12.20% |
Normalized Earnings Yield | -12.87 |